 |
Katie Ballering
|
E-mail: balle028@umn.edu
Thesis Advisor: Gary
Dunny
Year entered: 2004
Degrees received:
B.S., Bacteriology, University of Wisconsin-Madison, 2004
Honors and Awards:
-
MPGI travel grant (2006)
-
MICaB travel grant (2007)
-
ASM General Meeting travel grant (2007)
-
Student Representative (2007-8)
- Dennis W. Watson Fellowship (2007-08)
- Student representative to the University of Minnesota
Board of Regents Equity, Access and Diversity committee
(2006-2010)
Thesis research:
Enterococcus faecalis is one of the top three nosocomial
pathogens in the US and is a major vector for dissemination
of antibiotic resistance through horizontal gene transfer
biofilm formation likely plays a role in both of these processes.
To understand the genetic mechanisms driving the formation
of a biofilm and the role of biofilm formation in E. faecalis
pathogenesis we used a genetic method that allows for the
identification and characterization of biofilm-specific gene
regulatory circuits at all stages of biofilm development.
We refined a Recombinase-Based In Vivo Expression
Technology (RIVET) system to identify promoters that are specifically
expressed during E. faecalis biofilm formation. Screening
of the RIVET library yielded 68 unique clones containing biofilm
activated genomic segments, including several putative promoters
driving expression of genes previously found to be involved
in biofilm formation in other organisms, as well biofilm-activated
genes of unknown function. Using qPCR we have demonstrated
induced transcription of several RIVET-identified genes including
EF_1809. EF_1809 has been annotated <www.tigr.org> as
a GntR-family transcriptional regulator. This gene has not
yet been functionally characterized in E. faecalis.
To understand the role of EF_1809 in biofilm formation in
this organism we used allelic exchange to create a non-polar
null mutation in this locus. The biofilm formation abilities
of this mutant were compared to that of the wild type strain
using viable counts after 24 hours of biofilm growth as a
measurement. The EF_1809 null mutant was reduced in biofilm
formation by more than 90%. This defect was complemented by
expressing the cloned EF_1809 gene in trans from a plasmid.
Therefore we conclude that EF_1809 plays a significant role
in biofilm formation in E. faecalis. We
hypothesize that expression of EF_1809 is activated following
the initiation of biofilm growth, and that it regulates expression
of other genetic determinants required for full development
of biofilms. Current efforts are directed toward testing this
model and toward determination of the molecular mechanisms
of activation of EF_1809 expression during biofilm growth
and its regulatory effects on downstream target genes.
|